Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Study of Telbivudine on Liver Cirrhosis in Patients With Chronic Hepatitis B

NCT01380951 is registered in ClinicalTrials.gov with The Fifth People's Hospital of Suzhou as lead sponsor.

NCT NCT01380951
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01380951 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Study of Telbivudine on Liver Cirrhosis in Patients With Chronic Hepatitis B
Lead sponsor
The Fifth People's Hospital of Suzhou
Phase
Phase 4
Overall status
Unknown status
Start date
May 31, 2011
Completion date
December 31, 2013
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic hepatitis b, liver cirrhosis